EZH2 inhibitors can relieve the severity of liver failure in mice, which may be related to the reduction in H3K27me3 and the downregulation of liver pro-inflammatory cytokines (Zhou T. et al. 2018). This evidence concerns the gene EZH2 and Hepatic failure.